

Cover Story
NCI
By Claire Marie Porter and Paul Goldberg
Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute whose research is focused on apoptosis and functional diagnostics, has been tapped by the Trump administration to become the 18th director of the National Cancer Institute.
Podcast
Cancer Policy
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- How will FDA regulate psychedelics?
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Vermont researchers discover transmissible cancer in catfish—first ever in a freshwater animal




















